J&J earnings hit by litigation and recalls – Financial Times
Charges related to litigation and product recalls led to a steep decline in fourth-quarter earnings at Johnson & Johnson, the US healthcare company. J&J said on Tuesday that its net income during the final three months of last year fell by 88.8 ...
Subscribe to LegalLaw247.Com Newsletter